INS and Hypoglycemia: Patients were enrolled for varying reasons including lack of efficacy of premixed insulin (7% < HbA1c < 10%), wanting a more flexible lifestyle, frequent occurrence of hypoglycemia with previous therapy, and lack of tolerability of the previous therapy.